Opthea Ltd has released a press release.
Opthea European Patent Application to be Granted
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Opthea
- Opthea Provides Timing Update on OPT-302 Clinical Trials
- Opthea Completes Final Patient Visit in Phase 2b wAMD Trial
- S&P DJI Announces March 2019 Quarterly Rebalance
- Opthea Ph2b Trial Advances With 2nd Positive Safety Review
- Opthea Granted Japanese Patent Covering OPT-302
Later from Opthea
- Opthea Meets Primary Endpoint in Phase 2b Study of OPT-302
- Opthea Ph2b of OPT-302 in wAMD to be Presented at EURETINA
- Opthea Presentation for EURETINA Congress
- Opthea Receives A$14.6m R&D Tax Incentive
- Opthea Presentation for Ophthalmology Innovation Summit
Follow Opthea into a list and get an email when it puts out news.
Follow Opthea